{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T17:00:08Z","timestamp":1792947608618,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T00:00:00Z","timestamp":1765065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2025.e02452","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T16:56:49Z","timestamp":1765299409000},"page":"e02452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Probiotic paradox: Saccharomyces cerevisiae fungemia after S. boulardii use in severe pancreatitis"],"prefix":"10.1016","volume":"43","author":[{"given":"Vidit","family":"Dholakia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8319-4931","authenticated-orcid":false,"given":"Soumyadip","family":"Sain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvendu Sekhar","family":"Jena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiran","family":"Nundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.idcr.2025.e02452_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/1756283X11428502","article-title":"Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders","volume":"5","author":"Kelesidis","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02452_bib2","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00284-020-02053-9","article-title":"Saccharomyces boulardii CNCM I-745: A non-bacterial microorganism used as probiotic agent in supporting treatment of selected diseases","volume":"77","author":"Ka\u017amierczak-Siedlecka","year":"2020","journal-title":"Curr Microbiol"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02452_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5005\/jp-journals-10071-23239","article-title":"Saccharomyces: a friend or Foe in ICU (A Case Report with Solution)","volume":"23","author":"Gupta","year":"2019","journal-title":"Indian J Crit Care Med"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02452_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.idnow.2020.12.003","article-title":"Saccharomyces cerevisiae fungemia: risk factors, outcome and links with S. boulardii-containing probiotic administration","volume":"51","author":"Poncelet","year":"2021","journal-title":"Infect Dis Now"},{"issue":"11","key":"10.1016\/j.idcr.2025.e02452_bib5","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1469-0691.2010.03311.x","article-title":"Matrix-assisted laser desorption ionization time-of-flight mass spectrometry, a revolution in clinical microbial identification","volume":"16","author":"Bizzini","year":"2010","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02452_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0924-2244(99)00027-8","article-title":"Probiotics: how should they be defined?","volume":"10","author":"Salminen","year":"1999","journal-title":"Trends Food Sci Technol"},{"issue":"10","key":"10.1016\/j.idcr.2025.e02452_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nri.2017.55","article-title":"Fungal dysbiosis: immunity and interactions at mucosal barriers","volume":"17","author":"Iliev","year":"2017","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"10.1016\/j.idcr.2025.e02452_bib8","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1001\/jama.2012.3507","article-title":"Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis","volume":"307","author":"Hempel","year":"2012","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02452_bib9","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1128\/iai.64.12.5225-5232.1996","article-title":"Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum","volume":"64","author":"Castagliuolo","year":"1996","journal-title":"Infect Immun"},{"issue":"1\/4","key":"10.1016\/j.idcr.2025.e02452_bib10","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1023\/A:1020620607611","article-title":"Probiotics: an overview of beneficial effects","volume":"82","author":"Ouwehand","year":"2002","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02452_bib11","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/MCG.0b013e3181646d09","article-title":"Role of probiotics in antibiotic-associated diarrhea, Clostridium difficile-associated diarrhea, and recurrent Clostridium difficile-associated diarrhea","volume":"42","author":"Surawicz","year":"2008","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02452_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s100960050003","article-title":"Possible role of catheters in Saccharomyces boulardii fungemia","volume":"19","author":"Hennequin","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"11","key":"10.1016\/j.idcr.2025.e02452_bib13","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/497832","article-title":"Invasive Saccharomyces infection: a comprehensive review","volume":"41","author":"Enache-Angoulvant","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idcr.2025.e02452_bib14","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1086\/429916","article-title":"Saccharomyces cerevisiae fungemia: an emerging infectious disease","volume":"40","author":"Mu\u00f1oz","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02452_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.riam.2018.04.004","article-title":"Antifungal susceptibility of Saccharomyces cerevisiae and therapy in a murine model of disseminated infection","volume":"36","author":"P\u00e9rez-Cantero","year":"2019","journal-title":"Rev Ibero Micol"},{"key":"10.1016\/j.idcr.2025.e02452_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mmcr.2017.02.002","article-title":"Catheter-related saccharomyces cerevisiae fungemia following saccharomyces boulardii probiotic treatment: in a child in intensive care unit and review of the literature","volume":"15","author":"At\u0131c\u0131","year":"2017","journal-title":"Med Mycol Case Rep"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02452_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/313774","article-title":"Diagnosing postneurosurgical meningitis","volume":"30","author":"Johnson","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.idcr.2025.e02452_bib18","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3201\/eid1611.100574","article-title":"Regulatory oversight and safety of probiotic use","volume":"16","author":"Venugopalan","year":"2010","journal-title":"Emerg Infect Dis"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925003099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925003099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T23:09:04Z","timestamp":1775948944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925003099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"alternative-id":["S2214250925003099"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02452","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Probiotic paradox: Saccharomyces cerevisiae fungemia after S. boulardii use in severe pancreatitis","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02452"}}